National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

PAPERBACK
price:$21.00
add to cart

Rights & Permissions

topleft topright

CNS Clinical Trials: Suicidality and Data Collection: Workshop Summary (2010)
Board on Health Sciences Policy (HSP)

Citation Manager

. "Appendix B: Workshop Agenda." CNS Clinical Trials: Suicidality and Data Collection: Workshop Summary. Washington, DC: The National Academies Press, 2010.

Please select a format:

BibTeX EndNote RefMan


Page
52
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


CNS Clinical Trials: Suicidality and Data Collection - Workshop Summary
  • Examine potential partnerships among the FDA, pharmaceutical industry, academia, and the NIH that could be used to facilitate data sharing from randomized clinical trials.

9:00 a.m.

Welcome, Introductions, and Workshop Objectives

 

WILLIAM POTTER, Workshop Co-chair

Vice President

Clinical Neuroscience

Merck Research Laboratories

Merck & Co., Inc.

 

ROBERT GIBBONS, Workshop Co-chair

Director, Center for Health Statistics

Professor of Biostatistics and Psychiatry

University of Illinois at Chicago

9:15 a.m.

FDA Policies and Perspectives: Suicidality Studies in IND

 

THOMAS LAUGHREN

Director

Division of Psychiatry Products

Food and Drug Administration

9:35 a.m.

C-CASA and C-SSRS in CN S Clinical Trials: Development and Implementation

 

KELLY POSNER

Director

Center for Suicide Risk Assessment

New York State Psychiatric Institute

9:55 a.m.

Perspectives from the Patient Community

 

GAIL GRIFFITH

Consumer Representative

Food and Drug Administration’s

Psychopharmacological Drug Advisory Committee

Page
52